{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-000240","form_type":"8-K","ticker":"AURX","cik":"0001091596","company_name":"Nuo Therapeutics, Inc.","filed_at":"2022-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.389907+00:00","generated_at":"2026-06-27T20:51:15.720860+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Nuo Therapeutics modifies warrant exercise price; all warrants exercised for 6.87M shares and $1.37M","bullets":["Warrant exercise price reduced from $0.40 to $0.20 per share, with exercise required by Jan 31, 2022.","All 6,865,461 warrants exercised by Dec 30, 2021, raising $1,373,092 in gross proceeds.","Company issued 6.87M shares of common stock in exempt private placement under Section 4(a)(2) and 3(a)(9).","Warrants were originally issued in October 2020 recapitalization and for services to executives including CEO David Jorden."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-000240","json":"https://secwatch.observer/filing/0001437749-22-000240.json","markdown":"https://secwatch.observer/filing/0001437749-22-000240.md","text":"https://secwatch.observer/filing/0001437749-22-000240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922000240/0001437749-22-000240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922000240/aurx20220103_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:51:15.720860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}